 Hannah Robinson
Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 4 | 2025 | 799 | 1.250 |
Why?
| | Neoplasms, Unknown Primary | 1 | 2025 | 19 | 0.950 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 4 | 2025 | 1695 | 0.810 |
Why?
| | Receptor, ErbB-2 | 1 | 2024 | 342 | 0.730 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 414 | 0.700 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2025 | 683 | 0.640 |
Why?
| | CD3 Complex | 1 | 2018 | 106 | 0.570 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 73 | 0.550 |
Why?
| | Antigens, CD19 | 1 | 2018 | 123 | 0.550 |
Why?
| | Antibodies, Bispecific | 1 | 2018 | 54 | 0.550 |
Why?
| | Salvage Therapy | 1 | 2018 | 143 | 0.540 |
Why?
| | Antibodies, Monoclonal | 1 | 2023 | 1428 | 0.500 |
Why?
| | Pyrazoles | 1 | 2018 | 427 | 0.450 |
Why?
| | Pyrimidines | 1 | 2018 | 472 | 0.450 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2024 | 806 | 0.440 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1279 | 0.280 |
Why?
| | Microsatellite Instability | 1 | 2025 | 43 | 0.240 |
Why?
| | Neoplasm Metastasis | 2 | 2025 | 659 | 0.230 |
Why?
| | Bevacizumab | 1 | 2024 | 137 | 0.210 |
Why?
| | Benzimidazoles | 1 | 2024 | 169 | 0.210 |
Why?
| | B7-H1 Antigen | 1 | 2025 | 218 | 0.200 |
Why?
| | Cetuximab | 1 | 2023 | 95 | 0.200 |
Why?
| | Genomics | 1 | 2025 | 793 | 0.160 |
Why?
| | Disease Management | 1 | 2024 | 625 | 0.160 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1047 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 807 | 0.150 |
Why?
| | Single-Chain Antibodies | 1 | 2018 | 18 | 0.150 |
Why?
| | Mice, SCID | 1 | 2018 | 367 | 0.140 |
Why?
| | Piperidines | 1 | 2018 | 208 | 0.130 |
Why?
| | Mice, Inbred NOD | 1 | 2018 | 601 | 0.130 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 957 | 0.130 |
Why?
| | Adenine | 1 | 2018 | 268 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2025 | 10821 | 0.120 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 868 | 0.120 |
Why?
| | Mutation | 1 | 2025 | 3964 | 0.110 |
Why?
| | Aged, 80 and over | 1 | 2025 | 7593 | 0.100 |
Why?
| | Humans | 6 | 2025 | 137514 | 0.090 |
Why?
| | Aged | 3 | 2025 | 23798 | 0.090 |
Why?
| | Middle Aged | 3 | 2025 | 33355 | 0.080 |
Why?
| | Adult | 3 | 2025 | 37821 | 0.070 |
Why?
| | Leucovorin | 1 | 2025 | 83 | 0.060 |
Why?
| | Camptothecin | 1 | 2025 | 116 | 0.060 |
Why?
| | Fluorouracil | 1 | 2025 | 213 | 0.060 |
Why?
| | Male | 3 | 2025 | 67718 | 0.050 |
Why?
| | Microsatellite Repeats | 1 | 2024 | 168 | 0.050 |
Why?
| | Female | 3 | 2025 | 73162 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2025 | 892 | 0.050 |
Why?
| | Mice | 1 | 2018 | 17843 | 0.040 |
Why?
| | Animals | 1 | 2018 | 37011 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2025 | 15628 | 0.020 |
Why?
|
|
Robinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|